CRM
40
-2
HAS
63
3
BIIB
50
5
CNX
38
-3
EXR
59
4
AES
31
5
KMB
53
2
FITB
58
2
MAC
61
3
ABT
62
2
K
60
6
CVS
56
2
BBY
42
-8
CTSH
55
3
CF
54
-2
CL
54
3
AAP
42
-2
BMY
53
3
EMN
73
25
FOX
51
-9
CRM
40
-2
HAS
63
3
BIIB
50
5
CNX
38
-3
EXR
59
4
AES
31
5
KMB
53
2
FITB
58
2
MAC
61
3
ABT
62
2
K
60
6
CVS
56
2
BBY
42
-8
CTSH
55
3
CF
54
-2
CL
54
3
AAP
42
-2
BMY
53
3
EMN
73
25
FOX
51
-9
Financhill
Back

Apollo Asset Management, Inc. Vs. Akero Therapeutics Industry Stock Comparison

Sell
45

APO
Apollo Asset Management, Inc.

Last Price:
$131.68
Seasonality Move:
2.21%
Buy
60

AKRO
Akero Therapeutics

Last Price:
$48.05
Seasonality Move:
22.68%
Sell
45
Apollo Asset Management, Inc. (APO) is a Sell

Is Apollo Asset Management, Inc. a Buy, Sell or Hold?

  • The current Apollo Asset Management, Inc. [APO] share price is $131.70. The Score for APO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • APO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $48.03. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APO Stock Price Chart

What is Apollo Asset Management, Inc.'s stock price today?

  • The Apollo Asset Management, Inc. share price today is $131.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APO is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $48.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

APO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.31 Sell
Relative Strength Index (14 RSI): 45.26 Sell
Chaikin Money Flow: -609201 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (130.91 - 141.09) Sell
Bollinger Bands (100): (129.03 - 161.09) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.54 Buy
Relative Strength Index (14 RSI): 60.65 Buy
Chaikin Money Flow: 1377027 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.05 - 46.51) Buy
Bollinger Bands (100): (32.97 - 50.31) Buy

APO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 133.83 Sell
20-day SMA: 136.14 Sell
50-day SMA: 133.53 Sell
200-day SMA: 143.18 Sell
8-day EMA: 133.65 Sell
20-day EMA: 134.77 Sell
50-day EMA: 136.41 Sell
200-day EMA: 138.43 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.09 Buy
20-day SMA: 43.46 Buy
50-day SMA: 41.57 Buy
200-day SMA: 35.24 Buy
8-day EMA: 45.76 Buy
20-day EMA: 43.88 Buy
50-day EMA: 42.47 Buy
200-day EMA: 36.86 Buy

Apollo Asset Management, Inc. Earnings Growth & APO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.32 per share, an increase this year of $0.68 per share, and an increase next year of $1.60 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.63 per share.

Apollo Asset Management, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):